Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2017

Open Access 01-12-2017 | Research article

Prevalence of and risk factors for severe cognitive and sleep symptoms in ME/CFS and MS

Authors: Vageesh Jain, Amit Arunkumar, Caroline Kingdon, Eliana Lacerda, Luis Nacul

Published in: BMC Neurology | Issue 1/2017

Login to get access

Abstract

Background

There are considerable phenotypic and neuroimmune overlaps between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis (MS). While the precise aetiologies of both MS and ME/CFS are unclear, evidence suggests that deterioration in cognitive function is widely prevalent in patients with either condition. Little is known about differing risk factors or exposures, which may lead to severe cognitive or sleep symptoms. This study aims to gauge the extent of cognitive and sleep symptoms in ME/CFS and MS patients participating in the UK ME/CFS Biobank and identify the characteristics of those experiencing severe symptoms.

Methods

This was a cross-sectional study of 395 UK ME/CFS Biobank participants, recruited from primary care and the community, using similar standardised protocols, and matched by age, sex and geographical area. Data were collected from participants using a standardized written questionnaire at clinical visits. Cognitive symptoms included problems with short-term memory, attention, and executive function. Sleep symptoms included unrefreshing sleep and poor quality or inadequate duration of sleep. All participants reported symptoms based on an ordinal severity scale. Multivariable logistic regression was carried out in the ME/CFS group to investigate socio-demographic factors associated with severe symptoms.

Results

All cognitive and sleep symptoms were more prevalent in the ME/CFS group, with ‘trouble concentrating’ (98.3%) the most commonly reported symptom. Severe symptoms were also more commonly reported in the ME/CFS group, with 55% reporting ‘severe, unrefreshing sleep’. Similarly, in the MS group, the most commonly reported severe symptoms were sleep-related. Logistic regression analysis revealed that ME/CFS patients aged over 50 years were more than three times as likely to experience severe symptoms than those younger than 30 (OR 3.23, p = 0.031). Current smoking was associated with severe symptoms, increasing the risk by approximately three times (OR 2.93, p = 0.003) and those with household incomes of more than £15,000 per year were less likely to experience severe symptoms compared to those earning less than this (OR 0.31, p = 0.017).

Conclusions

Cognitive and sleep symptoms are more common in ME/CFS patients than in MS patients and healthy controls, providing further support for existing evidence of central nervous system abnormalities in ME/CFS. Our findings suggest that people with ME/CFS who are smokers, or have a low income, are more likely to report severe cognitive and sleep symptoms. Future research should aim to develop strategies to prevent the progression of severe cognitive and sleep symptoms through early interventions that prioritise patients identified as being at highest risk.
Literature
1.
Clayton EW. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA. 2015;313(11):1101–2.CrossRefPubMed
2.
McDonald WI, Compston A, Edan G, Goodkin D, Hartung H, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121–7.CrossRefPubMed
3.
Ablashi D, Eastman H, Owen C, Roman M, Friedman J, Zabriskie J, et al. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol. 2000;16(3):179–91.CrossRefPubMed
4.
Chaudhuri A, Behan PO. Neurological dysfunction in chronic fatigue syndrome. J Chronic Fatigue Syndrome. 2000;6(3–4):51–68.CrossRef
5.
White AT, Light AR, Hughen RW, Vanhaitsma TA, Light KC. Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls. Psychosom Med. 2012;74(1):46–54.CrossRefPubMed
6.
Robertson MJ, Schacterle R, Mackin G, Wilson S, Bloomingdale K, Ritz J, et al. Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression. Clinical & Experimental Immunology. 2005;141(2):326–32.CrossRef
7.
Frykholm B. On the question of infectious aetiologies for multiple sclerosis, schizophrenia and the chronic fatigue syndrome and their treatment with antibiotics. Med Hypotheses. 2009;72(6):736–9.CrossRefPubMed
8.
Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndrome. 2003;11(1):7–115.CrossRef
9.
Jongen PJ, Ter Horst AT, Brands AM. Cognitive impairment in multiple sclerosis. Minerva Med. 2012;103(2):73–96.PubMed
10.
Logsdon RG, Gibbons LE, McCurry SM, Teri L. Assessing quality of life in older adults with cognitive impairment. Psychosom Med. 2002;64(3):510–9.CrossRefPubMed
11.
Krupp LB, Jandorf L, Coyle P, Mendelson W. Sleep disturbance in chronic fatigue syndrome. J Psychosom Res. 1993;37(4):325–31.CrossRefPubMed
12.
Kaynak H, Altintaş A, Kaynak D, Uyanik Ö, Saip S, Ağaoğlu J, et al. Fatigue and sleep disturbance in multiple sclerosis. Eur J Neurol. 2006;13(12):1333–9.CrossRefPubMed
13.
Morris G, Maes M. Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics. BMC Med. 2013;11:205-7015-11-205.
14.
Maes M. Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms. Current opinion in psychiatry. 2009;22(1):75–83.CrossRefPubMed
15.
Uveges JM, Parker JC, Smarr KL, McGowan JF, Lyon MG, Irvin WS, et al. Psychological symptoms in primary fibromyalgia syndrome: relationship to pain, life stress, and sleep disturbance. Arthritis & Rheumatism. 1990;33(8):1279–83.CrossRef
16.
McClintock SM, Husain MM, Greer TL, Cullum CM. Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. Neuropsychology. 2010;24(1):9.CrossRefPubMed
17.
18.
DeCarli C. Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. The Lancet Neurology. 2003;2(1):15–21.CrossRefPubMed
19.
20.
Lacerda EM, Bowman EW, Cliff JM, Kingdon CC, King EC, Lee JS, et al. The UK ME/CFS Biobank for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis. Open Journal of Bioresources 2017 In Press.
21.
22.
Baker R, Shaw E. Guidelines: diagnosis and management of chronic fatigue syndrome or myalgic encephalomyelitis (or encephalopathy): summary of NICE guidance. BMJ: British Medical Journal. 2007;335(7617):446–8.CrossRefPubMedPubMedCentral
23.
StataCorp. Stata statistical software: release 14. 2015.
24.
Kirkwood BR, Sterne JA. Essential medical statistics. Wiley; 2010.
25.
Boyede GO, Lesi FE, Ezeaka VC, Umeh CS. Impact of sociodemographic factors on cognitive function in school-aged HIV-infected Nigerian children. HIV AIDS (Auckl). 2013;5:145–52.
26.
Einarsson U, Gottberg K, von Koch L, Fredrikson S, Ytterberg C, Jin YP, et al. Cognitive and motor function in people with multiple sclerosis in Stockholm County. Mult Scler. 2006;12(3):340–53.CrossRefPubMed
27.
28.
Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med. 1994;121(12):953–9.CrossRefPubMed
29.
30.
Hempel S, Chambers D, Bagnall A, Forbes C. Risk factors for chronic fatigue syndrome/myalgic encephalomyelitis: a systematic scoping review of multiple predictor studies. Psychol Med. 2008;38(7):915–26.CrossRefPubMed
31.
Chalder T, Goodman R, Wessely S, Hotopf M, Meltzer H. Epidemiology of chronic fatigue syndrome and self reported myalgic encephalomyelitis in 5-15 year olds: cross sectional study. BMJ. 2003;327(7416):654–5.CrossRefPubMedPubMedCentral
32.
Huibers MJ, Bleijenberg G, van Amelsvoort LG, Beurskens AJ, van Schayck CP, Bazelmans E, et al. Predictors of outcome in fatigued employees on sick leave: results from a randomised trial. J Psychosom Res. 2004;57(5):443–9.CrossRefPubMed
33.
Viner R, Hotopf M. Childhood predictors of self reported chronic fatigue syndrome/myalgic encephalomyelitis in adults: national birth cohort study. BMJ. 2004;329(7472):941.CrossRefPubMedPubMedCentral
34.
White PD, Thomas JM, Kangro HO, Bruce-Jones WD, Amess J, Crawford DH, et al. Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet. 2001;358(9297):1946–54.CrossRefPubMed
35.
Kato K, Sullivan PF, Evengård B, Pedersen NL. Premorbid predictors of chronic fatigue. Arch Gen Psychiatry. 2006;63(11):1267–72.CrossRefPubMed
36.
Bell KM, Cookfair D, Bell DS, Reese P, Cooper L. Risk factors associated with chronic fatigue syndrome in a cluster of pediatric cases. Review of Infectious Diseases. 1991;13(Supplement 1):S32–8.CrossRef
37.
Volkow ND, Gur RC, Wang G, Fowler JS, Moberg PJ, Ding Y, et al. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry. 1998;155(3):344–9.PubMed
38.
Yoshiuchi K, Farkas J, Natelson BH. Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. Clin Physiol Funct Imaging. 2006;26(2):83–6.CrossRefPubMed
39.
Reeves WC, Jones JF, Maloney E, Heim C, Hoaglin DC, Boneva RS, et al. Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Popul Health Metrics. 2007;5(1):1.CrossRef
40.
Lutgendorf SK, Antoni MH, Ironson G, Fletcher MA, Penedo F, Baum A, et al. Physical symptoms of chronic fatigue syndrome are exacerbated by the stress of hurricane Andrew. Psychosom Med. 1995;57(4):310–23.CrossRefPubMed
41.
Grandner MA, Petrov M, Rattanaumpawan P, Jackson N, Platt A, Patel NP. Sleep symptoms, race/ethnicity, and socioeconomic position. J Clin Sleep Med. 2013;9(9):897–905.PubMedPubMedCentral
42.
Ott A, Andersen K, Dewey ME, Letenneur L, Brayne C, Copeland JR, et al. Effect of smoking on global cognitive function in nondemented elderly. Neurology. 2004;62(6):920–4.CrossRefPubMed
43.
Minden SL, Schiffer RB. Depression and mood disorders in multiple sclerosis. Cogn Behav Neurol. 1991;4(1):62–77.
44.
Arnett PA, Barwick FH, Beeney JE. Depression in multiple sclerosis: review and theoretical proposal. J Int Neuropsychol Soc. 2008;14(05):691–724.CrossRefPubMed
45.
Arnett PA, Higginson CI, Voss WD, Bender WI, Wurst JM, Tippin JM. Depression in multiple sclerosis: relationship to working memory capacity. Neuropsychology. 1999;13(4):546.CrossRefPubMed
46.
Arnett PA, Higginson CI, Voss WD, Wright B, Bender WI, Wurst JM, et al. Depressed mood in multiple sclerosis: relationship to capacity-demanding memory and attentional functioning. Neuropsychology. 1999;13(3):434.CrossRefPubMed
47.
Denney DR, Lynch SG, Parmenter BA, Horne N. Cognitive impairment in relapsing and primary progressive multiple sclerosis: mostly a matter of speed. J Int Neuropsychol Soc. 2004;10(07):948–56.CrossRefPubMed
48.
Whelton CL, Salit I, Moldofsky H. Sleep, Epstein-Barr virus infection, musculoskeletal pain, and depressive symptoms in chronic fatigue syndrome. J Rheumatol. 1992;19(6):939–43.PubMed
49.
Metadata
Title
Prevalence of and risk factors for severe cognitive and sleep symptoms in ME/CFS and MS
Authors
Vageesh Jain
Amit Arunkumar
Caroline Kingdon
Eliana Lacerda
Luis Nacul
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2017
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-017-0896-0

Other articles of this Issue 1/2017

BMC Neurology 1/2017 Go to the issue

Research article

Isolated transient vertigo: posterior circulation ischemia or benign origin?

Case report

Case report: subacute tetraplegia in an immunocompromised patient

Research article

Validation of a leg movements count and periodic leg movements analysis in a custom polysomnography system

Research article

Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis

Study protocol

Randomized controlled trial of a coordinated care intervention to improve risk factor control after stroke or transient ischemic attack in the safety net: Secondary stroke prevention by Uniting Community and Chronic care model teams Early to End Disparities (SUCCEED)

Research article

Mindfulness-based interventions in epilepsy: a systematic review